Dear PAGE participants,
We gladly invite you to our one-and-a-half-day course, in which we will discuss
the importance of understanding the pharmacology of monoclonal antibodies
(mAbs) to make the right decisions in target-mediated drug disposition (TMDD)
model development.
After a short introduction, where we will directly dive into a hands-on
session, we’ll work in small groups on a TMDD modelling project using nlmixr2
within a shinyMixR workflow.
LAP&P’s interactive training will be held on Monday the 2nd of June 2025 (13 –
17) and Tuesday the 3rd of June (9-17) in Thessaloniki - Greece.
Find more information and register for the course on LAP&P course |
https://lapp.nl/lapp-course/ or on the PAGE website under Satellite
Meetings.
Please not that early bird fees apply until 1st of April, and in case of
question feel free to reach out!
Hope to see you there!
Tamara van Steeg
Tamara van Steeg, PhD
LAP&P Consultants
Leiden, The Netherlands
Web: http://www.lapp.nl/